2. Gene
  3. Cp - ceruloplasmin Gene

Cp - ceruloplasmin Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Mus musculus

同用名: D3Ertd555e

基因 ID: 12870 | 基因类型: protein coding

关于 Cp

功能概要

The protein encoded by this gene is a copper-containing glycoprotein found soluble in the serum and GPI-anchored in Other tissues. It oxidizes Fe(II) to Fe(III) and is proposed to play an important role in iron homeostasis. In humans mutations of this gene cause aceruloplasminemia, which is characterized by retinal degeneration, diabetes, anemia and neurological symptoms. In mouse deficiency of this gene in combination with a deficiency of its homolog hephaestin causes retinal degeneration and serves as a pathophysiological model for aceruloplasminemia and age-related macular degeneration. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Jan 2013]

Cp 基因产物(10)

mRNA Protein Name
NM_001276248.2 NP_001263177.1 ceruloplasmin isoform c precursor
NM_001276250.2 NP_001263179.1 ceruloplasmin isoform c precursor
NM_001374677.1 NP_001361606.1 ceruloplasmin isoform d precursor
NM_001409646.1 NP_001396575.1 ceruloplasmin isoform a precursor
NM_001409647.1 NP_001396576.1 ceruloplasmin isoform a precursor
NM_001409648.1 NP_001396577.1 ceruloplasmin isoform e precursor
NM_001409649.1 NP_001396578.1 ceruloplasmin isoform f precursor
NM_001409650.1 NP_001396579.1 ceruloplasmin isoform g precursor
NM_001409651.1 NP_001396580.1 ceruloplasmin isoform h precursor
NM_007752.4 NP_031778.2 ceruloplasmin isoform b precursor
基因本体论
  • 分子功能
  • 细胞组分
分子功能 GO 注释 逻辑证据 参考文献 来源
enables copper ion binding IDA
IDA: 通过直接分析推断
15634671 MGI
enables ferroxidase activity IDA
IDA: 通过直接分析推断
16436657 MGI
细胞组分 GO 注释 逻辑证据 参考文献 来源
located in extracellular space IDA
IDA: 通过直接分析推断
16436657 MGI
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断
蛋白主名 其他名称

ceruloplasmin

ferroxidase

相关产品

Approval
生物活性分子 (35)
目录号 产品名 作用方式
纯度 是否罕见病
HY-40354 Tofacitinib 99.99% 是
HY-50896 Erlotinib 99.99% 是
HY-14275 Verapamil 99.96% 是
HY-A0064 Verapamil hydrochloride 99.98% 是
HY-17506 Azithromycin Inhibitor 98.0% 是
HY-40354A Tofacitinib citrate 99.94% 是
HY-B0334 Sulbactam Inhibitor 99.97% 否
HY-12008 Erlotinib Hydrochloride 99.94% 是
HY-10019 Varenicline Agonist 99.92% 是
HY-14542 Ziprasidone Antagonist 99.35% 否
HY-B0253 Piroxicam Inhibitor 99.78% 否
HY-B0210A Cefoperazone sodium salt Inhibitor 99.55% 是
HY-10021 Varenicline Tartrate 99.96% 是
HY-B0334A Sulbactam sodium Inhibitor 99.66% 否
HY-10020 Varenicline Hydrochloride Agonist 99.94% 是
HY-B0254 Glipizide Inhibitor 99.83% 否
HY-A0037 Lasofoxifene 99.27% 否
HY-13538 Gemcitabine elaidate 98.90% 否
HY-A0038 Lasofoxifene tartrate Modulator 99.93% 否
HY-17506A Azithromycin hydrate Inhibitor 98.0% 是
HY-17484 Ampiroxicam 98.73% 否
HY-13010 Laquinimod 99.46% 是
HY-17407 Ziprasidone hydrochloride monohydrate Antagonist 98.11% 否
HY-A0064R Verapamil hydrochloride (Standard) 99.81% 否
HY-14542A Ziprasidone hydrochloride Antagonist 99.74% 否
HY-B0915 Orbifloxacin Inhibitor 99.78% 否
HY-108880 Carindacillin sodium Inhibitor 96.73% 否
HY-B0210AR Cefoperazone sodium salt (Standard) Inhibitor 99.07% 否
HY-10019A Varenicline dihydrochloride Agonist 99.21% 是
HY-108288 Sulbactam pivoxil Inhibitor 98.0% 否
HY-B0501 Danofloxacin mesylate Inhibitor 99.88% 否
HY-14542B Ziprasidone mesylate trihydrate Antagonist / 否
HY-108288R Sulbactam pivoxil (Standard) Inhibitor / 否
HY-14542C Ziprasidone mesylate Antagonist / 否
HY-12008A Erlotinib mesylate / 否
抗体抑制剂 (2)
目录号 产品名 作用方式
纯度 是否罕见病
HY-P9918 Tremelimumab 99.50% 否
HY-P99965 Crovalimab Inhibitor 99.59% 否
Clinical Phase
生物活性分子 (32)
目录号 产品名 作用方式
纯度 Phase
HY-N0678 Icaritin Inducer 99.06% Phase 4
HY-124498 Oxantel Inhibitor / Phase 4
HY-10211 Tanespimycin 99.01% Phase 3
HY-13223 Crenolanib 99.68% Phase 3
HY-105284 Sulopenem Inhibitor 99.16% Phase 3
HY-12089 Torcetrapib Inhibitor 99.59% Phase 3
HY-10871 Otenabant Antagonist 99.23% Phase 3
HY-14941 Elacytarabine ≥98.0% Phase 3
HY-10871A Otenabant Hydrochloride Antagonist / Phase 3
HY-105086 Pamaqueside Inhibitor / Phase 3
HY-P1717A AMY-101 TFA Inhibitor 99.92% Phase 2
HY-W018061 Traxoprodil Antagonist 99.92% Phase 2
HY-14674 CP-724714 98.72% Phase 2
HY-13302 CP-547632 Inhibitor 99.94% Phase 2
HY-14839 Evatanepag Agonist 99.78% Phase 2
HY-13302B CP-547632 hydrochloride Inhibitor 99.88% Phase 2
HY-13538A Gemcitabine elaidate hydrochloride 97.39% Phase 2
HY-10049 CP 122721 Antagonist / Phase 2
HY-105192 CP-122288 Agonist / Phase 2
HY-106106 Tiqueside Inhibitor / Phase 2
HY-120057 CP-331684 Agonist / Phase 2
HY-14129 CP 316311 Antagonist / Phase 2
HY-149769 CP-506 Substrate / Phase 2
HY-16372 CP 461 / Phase 2
HY-19193 CP-105696 Antagonist 99.93% Phase 1
HY-P1717 AMY-101 Inhibitor 99.86% Phase 1
HY-16373 CP-609754 Inhibitor 99.21% Phase 1
HY-12946 BI 653048 Inhibitor 99.84% Phase 1
HY-13223A Crenolanib benzenesulfonate 99.45% Phase 1
HY-105316 CP-800569 Inhibitor / Phase 1
HY-12946A BI 653048 phosphate Inhibitor / Phase 1
HY-U00401 (Rac)-CP-609754 Inhibitor / Phase 1
抗体抑制剂 (1)
目录号 产品名 作用方式
纯度 Phase
HY-P99197 Figitumumab Inhibitor ≥99.0% Phase 2
Pre-clinical Phase
生物活性分子 (299)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-12815 MCC950 Inhibitor 99.78% 否
HY-12815A MCC950 sodium Inhibitor 99.75% 否
HY-B1368 Fenclonine Inhibitor 99.92% 否
HY-12050 CP-673451 Inhibitor 99.69% 否
HY-13525 CP-91149 99.80% 否
HY-108347 CP-100356 hydrochloride Inhibitor 99.68% 否
HY-112136 TAO Kinase inhibitor 1 99.81% 否
HY-P1717B AMY-101 acetate Inhibitor 99.93% 否
HY-108615 CP-316819 Inhibitor 99.0% 否
HY-139330 MGH-CP1 Inducer 99.56% 否
HY-100207 CP21R7 Inhibitor 99.74% 否
HY-49116 CP26 Inhibitor 98.19% 否
HY-103068 Diethyl-pythiDC 99.90% 否
HY-115319 CP-24879 hydrochloride 99.59% 否
HY-12506A Naspm trihydrochloride Inhibitor 98.50% 否
HY-W018845 [Ir(Cp-)Cl2]2 ≥99.0% 否
HY-N0245 Theaflavin-3-gallate Inducer 99.89% 否
HY-W019734 [Rh(Cp-)Cl2]2 98.20% 否
HY-15259 CP-640186 Inhibitor 99.72% 否
HY-15662 Tulathromycin A Inhibitor 98.0% 否
HY-12506 Naspm Inhibitor 96.30% 否
HY-B1161A S-Methoprene Antagonist 98.58% 否
HY-18343A CP-31398 dihydrochloride p53 Activator 99.63% 否
HY-123772 CDK5 inhibitor 20-223 Inhibitor 99.62% 否
HY-125835 CP-10 Inhibitor 98.41% 否
HY-103151 CP94253 hydrochloride Agonist 98.84% 否
HY-11002 CP-466722 Inhibitor 99.74% 否
HY-15259A CP-640186 hydrochloride Inhibitor 99.65% 否
HY-130257 CP5V Inhibitor 99.31% 否
HY-14899 Taprenepag Agonist 98.79% 否
HY-150082 CP681301 Inhibitor 99.18% 否
HY-125843 Pomalidomide-PEG1-C2-N3 99.63% 否
HY-105064D Zoniporide hydrochloride hydrate Inhibitor 99.37% 否
HY-15243 Capromorelin Tartrate Agonist 98.10% 否
HY-12129 CP 154526 hydrochloride Antagonist 99.76% 否
HY-105028 Tenidap Inhibitor 99.32% 否
HY-113955 CP-346086 99.18% 否
HY-124815 CP-312 Inducer 99.69% 否
HY-19396 Ingliforib Inhibitor 99.07% 否
HY-19687 Zopolrestat Inhibitor 99.92% 否
HY-17506S Azithromycin-d3 Inhibitor 99.7% 否
HY-14130 CP 376395 Antagonist 99.59% 否
HY-120160 Darglitazone Agonist 99.19% 否
HY-W187279 Karrikin 2 99.17% 否
HY-103070 PythiDC Inhibitor 99.05% 否
HY-105445 CP-113818 Inhibitor 99.70% 否
HY-113421 Linoleoyl ethanolamide 98.0% 否
HY-101357A CP 93129 dihydrochloride Agonist 99.0% 否
HY-130841 Apcin-A Inhibitor 98.0% 否
HY-A0064S Verapamil-d3 hydrochloride 99.57% 否
HY-116006 Bis-PEG5-acid 99.90% 否
HY-130296 Palbociclib-propargyl 96.12% 否
HY-15543A CP-809101 hydrochloride Agonist 98.61% 否
HY-164605 (6S)-CP-470711 Inhibitor 98.75% 否
HY-19360 Sulprostone Agonist ≥99.0% 否
HY-A0104C HPMC (Type I,Viscosity:400mPa.s) / 否
HY-119721 CP-424174 Inhibitor 98.03% 否
HY-13256 Desmethyl Erlotinib hydrochloride 99.23% 否
HY-136951 cp028 Inhibitor 99.71% 否
HY-40354AS Tofacitinib-d3 citrate 99.59% 否
HY-W011085 CP-471474 Inhibitor 99.2% 否
HY-108571 CP-775146 Agonist 98.70% 否
HY-116530 9-Cyclopentyladenine monomethanesulfonate Inhibitor 99.95% 否
HY-116893 Diethyl bipy55'DC Inhibitor 98.79% 否
HY-12095 CB1 inverse agonist 2 Agonist 99.15% 否
HY-18663 CP-465022 Antagonist 98.24% 否
HY-101803 CP671305 Inhibitor 99.95% 否
HY-105064 Zoniporide Inhibitor 99.89% 否
HY-107634 CP-20961 Inducer 98.34% 否
HY-108574 CP 339818 hydrochloride Inhibitor 99.61% 否
HY-116699 CP-868388 free base Agonist 99.66% 否
HY-118140 ZCZ011 Modulator 99.43% 否
HY-130452 NOS1-IN-1 Inhibitor 95.0% 否
HY-40354S Tofacitinib-13C3 99.77% 否
HY-113421S Linoleoyl ethanolamide-d4 99.2% 否
HY-13340 VU0152100 Modulator 98.98% 否
HY-108482 CP-96,345 Inhibitor 99.9% 否
HY-116082 CP 226269 Agonist 99.65% 否
HY-136608 5-AAM-2-CP Agonist 99.22% 否
HY-136609 5-AMAM-2-CP Agonist 98.21% 否
HY-138879 CP-601927 Agonist 98.24% 否
HY-138879A (Rac)-CP-601927 hydrochloride Agonist 99.72% 否
HY-50896S Erlotinib-d6 Inhibitor 99.84% 否
HY-B0254S Glipizide-d11 Inhibitor 96.36% 否
HY-W018061C (R,R)-Traxoprodil Antagonist 99.00% 否
HY-118639 CP-74006 Inhibitor 98.86% 否
HY-160901 CP-289,503 Inhibitor 98.21% 否
HY-17506S1 Azithromycin-13C,d3 99.90% 否
HY-131959 (S,R,S)-AHPC-PEG5-Boc 95.29% 否
HY-108623 Atizoram Inhibitor 96.3% 否
HY-112199 CP-447697 Antagonist 99.70% 否
HY-12008S Erlotinib-d6 hydrochloride 98.13% 否
HY-121755 Tibric acid / 否
HY-123039 CP-532623 Inhibitor ≥99.0% 否
HY-13256A Desmethyl Erlotinib 98.77% 否
HY-13302C CP-547632 TFA Inhibitor 99.42% 否
HY-138879B CP-601932 Agonist 99.74% 否
HY-15541 Zaltidine Antagonist 99.49% 否
HY-163101 CP-96021 Antagonist 98.04% 否
HY-164749 K-Ras-IN-4 Inhibitor / 否
HY-179055 PROTAC DAPK1 Degrader-1 Degrader / 否
HY-B0253S Piroxicam-d3 Inhibitor 99.68% 否
HY-U00070 Dirlotapide 99.86% 否
HY-W772850 Fenclonine hydrochloride Inhibitor 98.60% 否
HY-101639 CP-409092 Agonist / 否
HY-13010S Laquinimod-d5 Inhibitor 98.25% 否
HY-177596A Dicytidine 5′-triphosphate trisodium Activator / 否
HY-B0334AS Sulbactam-d5 sodium Inhibitor 99.90% 否
HY-U00004 OSIP-486823 Inhibitor 98.0% 否
HY-18343 CP-31398 p53 Activator / 否
HY-W062904 Laquinimod sodium Inhibitor / 否
HY-10019AS1 Varenicline-d4 hydrochloride Agonist / 否
HY-10019S Varenicline-d4 Agonist / 否
HY-10019S1 Varenicline-15N,13C,d2 Agonist / 否
HY-10020S Varenicline-15N3 hydrochloride Agonist / 否
HY-10049A CP 122721 hydrochloride Antagonist / 否
HY-101357 CP 93129 Agonist / 否
HY-101558 Elzasonan Antagonist / 否
HY-101558A Elzasonan citrate Antagonist / 否
HY-101558B Elzasonan hydrochloride Antagonist / 否
HY-10211S Tanespimycin-d5 / 否
HY-103092 CP-135807 Agonist / 否
HY-103151A CP94253 Agonist / 否
HY-103379 CP 376395 hydrochloride Antagonist / 否
HY-105028S Tenidap-d3 Inhibitor / 否
HY-105064A Zoniporide mesylate Inhibitor / 否
HY-105064B Zoniporide hydrochloride Inhibitor / 否
HY-105064C Zoniporide dihydrochloride Inhibitor / 否
HY-105157 Icopezil Inhibitor / 否
HY-105205 Terlakiren Inhibitor / 否
HY-105358 CP-288886 Antagonist / 否
HY-105434 CP-74667 Inhibitor / 否
HY-106493 Tametraline Inhibitor / 否
HY-107013 CP-544439 Inhibitor / 否
HY-107213 Tulathromycin B Inhibitor / 否
HY-107233 Saponin CP4 / 否
HY-107235 Saponin CP6 / 否
HY-108347A CP-100356 Inhibitor / 否
HY-109855 CP-67015 Inhibitor / 否
HY-112742 CP-195543 Antagonist / 否
HY-113642 CP-67804 / 否
HY-113955A CP-346086 dihydrate / 否
HY-114540 CP-339818 Inhibitor / 否
HY-116142 CP-283097 Antagonist / 否
HY-117172 CP320626 Inhibitor / 否
HY-117803 CP 461 free base / 否
HY-117868 NC-174 / 否
HY-118056 ABD459 Antagonist / 否
HY-118625 CP-457920 Inhibitor / 否
HY-118842 Sunepitron hydrochloride / 否
HY-119080 CP8754 Antagonist / 否
HY-119142 CP-664511 Antagonist / 否
HY-120076 CP-293019 Antagonist / 否
HY-12008S1 Erlotinib-13C6 hydrochloride / 否
HY-120160A Darglitazone Sodium Agonist / 否
HY-12079 CP-481715 Antagonist / 否
HY-121293 CP-944629 Inhibitor / 否
HY-12130 CP 154526 Antagonist / 否
HY-12144 CP-99994 / 否
HY-12145 CP-99994 hydrochloride Inhibitor / 否
HY-121866 CP-84364 Inhibitor / 否
HY-122109A Levonantradol hydrochloride Agonist / 否
HY-122118 Lambast / 否
HY-122483 Diethyl pyimDC Inhibitor / 否
HY-123139 Flutroline / 否
HY-123203 CP-608039 Agonist / 否
HY-125627 CP-394531 Antagonist / 否
HY-130205 Milacemide hydrochloride Inhibitor / 否
HY-13256AS1 Desmethyl Erlotinib-d4-1 / 否
HY-135254 CP-46665 dihydrochloride Inhibitor / 否
HY-137607A UMP-CP trisodium Agonist / 否
HY-14275S1 Verapamil-d7 / 否
HY-14411 JNK-1-IN-1 Inhibitor / 否
HY-145126 CP-628006 Activator / 否
HY-14542S Ziprasidone-d8 Antagonist / 否
HY-145743 CP-17 Inhibitor / 否
HY-146815 CP19 / 否
HY-14839A Evatanepag sodium Agonist / 否
HY-149495 CP-07 Degrader / 否
HY-150665S N-Dansyl-d6 1,4-diaminobutane, 97% (CP) / 否
HY-151267 SARS-CoV-2-IN-25 Inhibitor / 否
HY-151267A SARS-CoV-2-IN-25 disodium Inhibitor / 否
HY-15242 Capromorelin Activator / 否
HY-155044 TMV-IN-5 Inhibitor / 否
HY-155045 TMV-IN-6 Inhibitor / 否
HY-15541A Zaltidine dihydrochloride Antagonist / 否
HY-161597 PROTAC DYRK2 degrader 1 / 否
HY-162807 TMV-IN-10 Inhibitor / 否
HY-163999 TMV-IN-12 Inhibitor / 否
HY-164698 CP-470711 Inhibitor / 否
HY-165444 CP-615003 Agonist / 否
HY-167946 CP-866087 Antagonist / 否
HY-168971 Paeoniflorin-6′-O-benzene sulfonate / 否
HY-169232 PCC16 chloride Degrader / 否
HY-16946 CP-610431 Inhibitor / 否
HY-171113 CP-LC-1074 / 否
HY-172014 CP-LC-0743 / 否
HY-174335 UVI3502 Antagonist / 否
HY-175233 Mesotrypsin IN-1 / 否
HY-176027 CP-LC-1422 / 否
HY-176751 TG-2-IN-5 Inhibitor / 否
HY-18228 CP-352664 Inhibitor / 否
HY-18663A CP-465022 maleate Antagonist / 否
HY-18663B CP-465022 hydrochloride Antagonist / 否
HY-19241 CP-85958 Antagonist / 否
HY-19277 CP-114271 Agonist / 否
HY-19454 CP-464709 Agonist / 否
HY-40354S1 Tofacitinib-13C3,15N 99.57% 否
HY-50896S1 Erlotinib-13C6 / 否
HY-A0064S1 Verapamil-d6 hydrochloride / 否
HY-B0253S1 Piroxicam-d4 Inhibitor / 否
HY-B0334AS1 Sulbactam-d2 sodium / 否
HY-B0501S Danofloxacin-d3 mesylate Inhibitor / 否
HY-B0915S Orbifloxacin-d5 hydrochloride Inhibitor / 否
HY-D1346 610CP / 否
HY-D1418 CP-BP-SFAC / 否
HY-E70937 Transcarbamylase, Streptococcus faecalis Ornithine / 否
HY-N0245R Theaflavin-3-gallate (Standard) Inducer / 否
HY-N10268 3-Hydroxyterphenyllin / 否
HY-N16303 CP-LC-1421 / 否
HY-N16318 CP-LC-1067 / 否
HY-P10384 SPSB2-iNOS inhibitory cyclic peptide-2 Inhibitor / 否
HY-P10385 SPSB2-iNOS inhibitory cyclic peptide-3 / 否
HY-P10828 MAPI Inhibitor / 否
HY-P11020 p27 Analogue CP2 Inhibitor / 否
HY-P11076 CP-EPS8-NLS Inhibitor / 否
HY-P11174 CP05 Ligand / 否
HY-P2024 CP-85339 Inhibitor / 否
HY-RS03079 CP Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W008914 (E/Z)-CP-724714 Inhibitor / 否
HY-W018061A Traxoprodil mesylate Antagonist / 否
HY-W115746A Ethyl cellulose (viscosity 10 cP) / 否
HY-W115746B Ethyl cellulose (viscosity 300 cP) / 否
HY-W654064 Azithromycin-13C,d3-1 / 否
HY-W879307 CP-201 / 否
HY-10019S2 Varenicline-13C15N Agonist / 否
HY-101731 CP-96021 hydrochloride Antagonist / 否
HY-105028A Tenidap sodium Inhibitor / 否
HY-105284A Sulopenem sodium Inhibitor / 否
HY-10814 CP-810123 Agonist / 否
HY-111129 CP-66713 Antagonist / 否
HY-111159 CP-467688 / 否
HY-111211 CP-457493 / 否
HY-119879 Binfloxacin Inhibitor / 否
HY-122174 ME-1036 Inhibitor / 否
HY-122284 CP-5068 Inhibitor / 否
HY-123289 CP-690550A Inhibitor / 否
HY-123311 CP59430 Antagonist / 否
HY-123571 CP-199330 Antagonist / 否
HY-123582 CP-866,087 / 否
HY-129698 MS-073 Inhibitor / 否
HY-129785 CP-220629 Inhibitor / 否
HY-129925 CP-49674 / 否
HY-14275S Verapamil-d3 / 否
HY-14275S2 Verapamil-d6 / 否
HY-149769A CP-506 mesylate Substrate 98.59% 否
HY-150346 1cP-MiPLA / 否
HY-15543 CP-809101 Agonist / 否
HY-15661A OSI-413 free base / 否
HY-15662S Tulathromycin A-d7 Inhibitor / 否
HY-165129 CP102 / 否
HY-169723 CP 524515 Inhibitor / 否
HY-171185 CP-611,781 / 否
HY-171476 CP-865569 Antagonist / 否
HY-171956 Carmaphycin-17 Inhibitor / 否
HY-172015 CP-LC-1143 / 否
HY-172016 CP-LC-0867 / 否
HY-172017 CP-LC-1254 / 否
HY-172018 CP-LC-0729 / 否
HY-172059 3C-P hydrochloride / 否
HY-172925 CP-LC-1447 / 否
HY-172926 CP-LC-1428 / 否
HY-174326 Antibacterial agent 282 Inhibitor / 否
HY-177596 Dicytidine 5′-triphosphate Activator / 否
HY-180272 TMV-IN-15 Inhibitor / 否
HY-19048 CP-66948 Antagonist / 否
HY-40354S2 Tofacitinib-13C,d3 / 否
HY-40354S3 Tofacitinib-13C / 否
HY-40354S5 Tofacitinib-d3 / 否
HY-50896S2 Erlotinib-d4 / 否
HY-50896S3 Erlotinib-d8 / 否
HY-B0253A Piroxicam olamine Inhibitor / 否
HY-B0334S Sulbactam-d3 Inhibitor / 否
HY-B2014 Alachlor / 否
HY-N13047 Ningnanmycin / 否
HY-P10200 CP7-FP13-2 Inhibitor / 否
HY-RS16625 Cp Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS23060 Cp Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-U00008 CP-28888 Inducer / 否
HY-W020041 CP 53631 Inhibitor / 否
HY-W1130407 CP-LC-1073 / 否
HY-W614725 Apcin-A monohydrochloride Inhibitor / 否
HY-W653875 Azithromycin-d5 Inhibitor / 否
HY-W936871 Hydrouracil-(4-CP) / 否
HY-100280 Pirolate Antagonist / 否
HY-100316 CP-96486 Antagonist / 否
HY-100332 CP 375 / 否
HY-U00270 CP-319340(free base) / 否
HY-U00354 CP-060 Antagonist / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Cp NCBI NCBI:1356
Canis familiaris Cp NCBI NCBI:442963
Macaca fascicularis Cp NCBI
Susscrofa domestica Cp NCBI
Rattus norvegicus Cp NCBI NCBI:24268
Macaca mulatta Cp NCBI NCBI:712210
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z